BridgeBio Pharma, Inc. (BBIO)

68.58 +0.67 (+0.99%) USD  |  NASDAQ  |  Feb 24, 13:10
More

BridgeBio Pharma Other Equity Adjustments (Quarterly)

Other Equity Adjustments (Quarterly) Chart

View Other Equity Adjustments (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Equity Adjustments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Equity Adjustments (Quarterly) Range, Past 5 Years

View Other Equity Adjustments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Equity Adjustments (Quarterly) Benchmarks

View Other Equity Adjustments (Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade